GRP
INO icon

Global Retirement Partners’s Inovio Pharmaceuticals INO Stock Holding History

Global Retirement Partners’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29
Closed -$1K – 2780
2022
Q1 		$1K Buy
+29
New +$1.31K ﹤0.01% 2420
2018
Q1 		– Sell
-224
Closed -$11K – 1512
2017
Q4 		$11K Sell
224
-99
-31% -$6.14K ﹤0.01% 877
2017
Q3 		$25K Sell
323
-263
-45% -$19.6K 0.01% 589
2017
Q2 		$55K Buy
586
+88
+18% +$7.53K 0.03% 394
2017
Q1 		$40K Sell
498
-66
-12% -$5.26K 0.02% 415
2016
Q4 		$47K Buy
+564
New +$51K 0.03% 362

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Global Retirement Partners's INO Position: Q2 2022 in Review

Global Retirement Partners sold out of Inovio Pharmaceuticals (INO) in Q2 2022, closing a stake of 29 shares — an estimated $1K sold.

Global Retirement Partners first reported a position in INO in Q4 2016 and held it in 6 quarters. The position peaked at $55K in Q2 2017. 184 funds tracked by Wall St. Rank hold INO as of Q2 2022.

  • Global Retirement Partners reported no remaining Inovio Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Global Retirement Partners sold 29 Inovio Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • Global Retirement Partners first reported a position in Inovio Pharmaceuticals in Q4 2016 and held it in 6 quarters.
  • Global Retirement Partners's Inovio Pharmaceuticals position peaked at $55K in Q2 2017.
  • 184 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2022.

Based on Global Retirement Partners's 13F filing for Q2 2022, filed 15 Jul 2022.